Schedule 13G ownership disclosure
VIRACTA THERAPEUTICS INC
Security class unavailable · CUSIP: 92765F108
Event date: 2021-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 0.7700%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-22-040610
- Form type
- SC 13G
- Filer
- Aisling Capital IV, LP
- CIK
- CIK 1652910
- Filed
- Feb 14, 2022
- Reporting period
- Dec 31, 2021
- Description
- Schedule 13G beneficial ownership